Search for Clinical Trial Results

Sponsored By

Hepatic Encephalopathy - 29 Studies Found

Status Study
Completed Study Name: Rifaximin in Minimal Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Date: 2007-09-20
Interventions:
  • Drug: Rifaximin 550mg BID rifa
Terminated Study Name: The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Date: 2013-05-01
Interventions: Drug: Rifaximin Participants in Phase B will be administered 550 mg of Rifaximin two times a day for 14
Completed Study Name: Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Condition: Hepatic Encephalopathy
Date: 2010-04-23
Interventions:
  • Drug: VSL#3 VSL#3® is mad
Completed Study Name: Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Date: 2010-08-02
Interventions:
  • Drug: Lactulose In the Gp-L gr
Completed Study Name: The Effects of Nitazoxanide in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Date: 2015-01-06
Interventions:
  • Drug: Nitazoxanide 500 mg nita
Completed Study Name: Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Date: 2010-08-09
Interventions:
  • Drug: Lactulose will receive 3
Not yet recruiting Study Name: Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy
Condition: Covert Hepatic Encephalopathy
Date: 2017-01-30
Interventions: Drug: Rifaximin The investigators use low-dose rifaximin for the treatment of patients with covert hepat
Terminated Study Name: Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Date: 2008-01-09
Interventions:
  • Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%

Completed Study Name: Cerebrovascular Reactivity in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Date: 2010-03-30
Completed Study Name: Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Date: 2008-08-21
Interventions:
  • Drug: L-ornithine-L-aspartate and lactulose

Next >>>